Compare PACB & QFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PACB | QFIN |
|---|---|---|
| Founded | 2000 | 2016 |
| Country | United States | China |
| Employees | N/A | 3557 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Finance: Consumer Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 690.6M |
| IPO Year | 2010 | 2018 |
| Metric | PACB | QFIN |
|---|---|---|
| Price | $2.84 | $5.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | $2.54 | ★ $14.86 |
| AVG Volume (30 Days) | ★ 14.9M | 1.9M |
| Earning Date | 11-04-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 27.46% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $93,468,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.01 | N/A |
| P/E Ratio | ★ N/A | $2.21 |
| Revenue Growth | ★ 3.04 | N/A |
| 52 Week Low | $1.07 | $5.23 |
| 52 Week High | $3.44 | $25.03 |
| Indicator | PACB | QFIN |
|---|---|---|
| Relative Strength Index (RSI) | 70.88 | 28.12 |
| Support Level | $1.24 | N/A |
| Resistance Level | $3.44 | $14.03 |
| Average True Range (ATR) | 0.24 | 0.25 |
| MACD | 0.04 | 0.11 |
| Stochastic Oscillator | 86.45 | 23.58 |
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
Qfin Holdings Inc is engaged in matching individual borrowers with credit demand to a diversified pool of financial institutions with credit to supply through a financial technology platform. It has released large-scale financial credit multimodal benchmark, building a critical bridge between credit AI research and real-world applications.